Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer

Author： Bharali Dhruba J   Yalcin Murat   Davis Paul J   Mousa Shaker A  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.8, Iss.12, 2013-12, pp. : 1943-1954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer

By Khaing Oo Maung Kyaw   Yang Xiaochuan   Du Henry   Wang Hongjun  

Nanomedicine, Vol. 3, Iss. 6, 2008-12 ,pp. : 777-786

Future Medicine

Access to resources Recommend Favorite

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

By Finney Michael S.   Crank Christopher W.   Segreti John  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1923-1926

Informa Healthcare

Access to resources Recommend Favorite

Liposomal nanomedicine for breast cancer therapy

By Paliwal Shivani Rai   Paliwal Rishi   Agrawal Govind P   Vyas Suresh P  

Nanomedicine, Vol. 6, Iss. 6, 2011-08 ,pp. : 1085-1100

Future Medicine

Access to resources Recommend Favorite

N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance

By Li Jing   Zhou Ping   Wang Yan   Chen Hongli   Zhang Cong   Li Rongshan   Yang Xiaoying   Wang Yinsong  

Journal of Microencapsulation, Vol. 31, Iss. 3, 2014-05 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

Development of radioresistance in drug resistant human MCF-7 breast cancer cells

By  

Journal of Radiotherapy in Practice, Vol. 8, Iss. 4, 2009-12 ,pp. : 207-213

Cambridge University Press

Access to resources Recommend Favorite